Plasma Proteomics for Novel Biomarker Development against Breast Cancer

Thursday, 24 May 2018 at 12:20

Add to Calendar ▼2018-05-24 12:20:002018-05-24 13:20:00Europe/LondonPlasma Proteomics for Novel Biomarker Development against Breast CancerBiomarkers - From Research To Commercialization in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

Yogeshwer Shukla, Chief Scientist, CSIR- Indian Institute of Toxicology Research

Yogeshwer Shukla

Dr. Yogeshwer Shukla is Chief Scientist at CSIR-Indian Institute of Toxicology Research, India. His research activities are Proteomics Prospects in Evaluation of Toxic/Carcinogenic Potential of Pesticides, Plasma Proteomics for Novel Biomarker Development Against Specific Cancer Types, Evaluation and Intervention of Genotoxic Potential of Pesticides, Nutritional Genomics and Proteomics in Cancer Chemoprevention, Studies on Genotoxic Potential of Environmental Pollutants, Expression and Repression Studies on Oncogenes during Experimental Carcinogenesis and Chemoprevention.